VERTEX PHARMACEUTICALS INC / MA: accounts_receivable
| Value | {"amount": 885400000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/509c4350-742b-496a-bc88-09c3045c4de0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-22-000007Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/509c4350-742b-496a-bc88-09c3045c4de0
History
- supersedes {"amount": 885352000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0000875320-21-000006)